1. |
马景学. 视网膜病[M]//杨培增, 范先群. 眼科学. 9版. 北京: 人民卫生出版社, 2018: 197.Ma JX. Reitnal diseases[M]//Yang BZ, Fan XQ. Ophthalmology. 9th ed. Beijing: People’ Medical Publishing House, 2018: 197.
|
2. |
Seddon JM, Sobrin L, Borkar DS. Epidemiology and risk factors for age-related macular degeneration[M]//Schachat AP. Ryan’s Retina. 6th ed. London: Elsevir, 2018: 1273-1284.
|
3. |
Gass JD. Drusen and disciform macular detachment and degeneration[J]. Trans Am Ophthalmol Soc, 1972, 70: 409-436.
|
4. |
Spaide RF, Jaffe GJ, Sarraf D, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group[J]. Ophthalmology, 2020, 127(5): 616-636. DOI: 10.1016/j.ophtha.2019.11.004.
|
5. |
Seddon JM, Sobrin L, Davoudi S. Epidemiology and risk factors for age-related macular degeneration[M]//Sadda SR. Ryan’s Retina. 7th ed. London: Elsevier, 2023: 1306.
|
6. |
Curcio CA, Spaide RF. Pathogenesis of age-related macular degeneration[M]//Sadda SR. Ryan’s Retina. 7th ed. London: Elsevier, 2023: 1324-1333.
|
7. |
Sakurada Y, Tanaka K, Fragiotta S. Differentiating drusen and drusenoid deposits subtypes on multimodal imaging and risk of advanced age-related macular degeneration[J]. Jpn J Ophthalmol, 2023, 67(1): 1-13. DOI: 10.1007/s10384-022-00943-y.
|
8. |
Wu Z, Fletcher EL, Kumar H, et al. Reticular pseudodrusen: a critical phenotype in age-related macular degeneration[J/OL]. Prog Retin Eye Res, 2022, 88: 101017[2021-11-06]. https://pubmed.ncbi.nlm.nih.gov/34752916/. DOI: 10.1016/j.preteyeres.2021.101017.
|
9. |
Chen L, Messinger JD, Zhang Y, et al. Subretinal drusenoid deposit in age-related macular degeneration: histologic insights into initiation, progression to atrophy, and imaging[J]. Retina, 2020, 40(4): 618-631. DOI: 10.1097/IAE.0000000000002657.
|
10. |
Xu X, Liu X, Wang X, et al. Retinal pigment epithelium degeneration associated with subretinal drusenoid deposits in age-related macular degeneration[J]. Am J Ophthalmol, 2017, 175: 87-98. DOI: 10.1016/j.ajo.2016.11.021.
|
11. |
Zhang Y, Wang X, Sadda SR, et al. Lifecycles of individual subretinal drusenoid deposits and evolution of outer retinal atrophy in age-related macular degeneration[J]. Ophthalmol Retina, 2020, 4(3): 274-283. DOI: 10.1016/j.oret.2019.10.012.
|
12. |
Monge M, Araya A, Wu L. Subretinal drusenoid deposits: an update[J]. Taiwan J Ophthalmol, 2022, 12(2): 138-146. DOI: 10.4103/tjo.tjo_18_22.
|
13. |
Agrón E, Domalpally A, Cukras CA, et al. Reticular pseudodrusen: the third macular risk feature for progression to late age-related macular degeneration: Age-Related Eye Disease Study 2 Report 30[J]. Ophthalmology, 2022, 129(10): 1107-1119. DOI: 10.1016/j.ophtha.2022.05.021.
|
14. |
Çeper SB, Afrashi F, Değirmenci C, et al. Multimodal imaging of reticular pseudodrusen in Turkish patients[J]. Turk J Ophthalmol, 2023, 53(5): 275-280. DOI: 10.4274/tjo.galenos.2023.85616.
|
15. |
Wu Z, Schmitz-Valckenberg S, Blodi BA, et al. Reticular pseudodrusen: interreader agreement of evaluation on OCT imaging in age-related macular degeneration[J/OL]. Ophthalmol Sci, 2023, 3(4): 100325[2023-05-05]. https://pubmed.ncbi.nlm.nih.gov/37292179/. DOI: 10.1016/j.xops.2023.100325.
|
16. |
Balaratnasingam C, Messinger JD, Sloan KR, et al. Histologic and optical coherence tomographic correlates in drusenoid pigment epithelium detachment in age-related macular degeneration[J]. Ophthalmology, 2017, 124(5): 644-656. DOI: 10.1016/j.ophtha.2016.12.034.
|
17. |
Grewal MK, Chandra S, Gurudas S, et al. Functional clinical endpoints and their correlations in eyes with AMD with and without subretinal drusenoid deposits-a pilot study[J]. Eye (Lond), 2022, 36(2): 398-406. DOI: 10.1038/s41433-021-01488-z.
|
18. |
Weber S, Simon R, Schwanengel LS, et al. Fluorescence lifetime and spectral characteristics of subretinal drusenoid deposits and their predictive value for progression of age-related macular degeneration[J]. Invest Ophthalmol Vis Sci, 2022, 63(13): 23. DOI: 10.1167/iovs.63.13.23.
|
19. |
Kaarniranta K, Blasiak J, Liton P, et al. Autophagy in age-related macular degeneration[J]. Autophagy, 2023, 19(2): 388-400. DOI: 10.1080/15548627.2022.2069437.
|
20. |
Zhang Y, Sadda SR, Sarraf D, et al. Spatial dissociation of subretinal drusenoid deposits and impaired scotopic and mesopic sensitivity in AMD[J]. Invest Ophthalmol Vis Sci, 2022, 63(2): 32. DOI: 10.1167/iovs.63.2.32.
|
21. |
Kar D, Corradetti G, Swain TA, et al. Choriocapillaris impairment is associated with delayed rod-mediated dark adaptation in age-related macular degeneration[J]. Invest Ophthalmol Vis Sci, 2023, 64(12): 41. DOI: 10.1167/iovs.64.12.41.
|
22. |
Wu Z, Zhou X, Chu Z, et al. Impact of reticular pseudodrusen on choriocapillaris flow deficits and choroidal structure on optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2022, 63(12): 1. DOI: 10.1167/iovs.63.12.1.
|
23. |
Wong JHC, Ma JYW, Jobling AI, et al. Exploring the pathogenesis of age-related macular degeneration: a review of the interplay between retinal pigment epithelium dysfunction and the innate immune system[J/OL]. Front Neurosci, 2022, 16: 1009599[2022-11-03]. https://pubmed.ncbi.nlm.nih.gov/36408381/. DOI: 10.3389/fnins.2022.1009599.
|
24. |
Kurzawa-Akanbi M, Whitfield P, Burté F, et al. Retinal pigment epithelium extracellular vesicles are potent inducers of age-related macular degeneration disease phenotype in the outer retina[J/OL]. J Extracell Vesicles, 2022, 11(12): e12295[2022-12-01]. https://pubmed.ncbi.nlm.nih.gov/36544284/. DOI: 10.1002/jev2.12295.
|
25. |
Budoff G, Leung LSB, Kaiser PK, et al. Pharmacotherapy of age-related macular degeneration[M]//Sadda SR. Ryan’s Retina. 7th ed. London: Elsevier, 2023: 1461-1465.
|
26. |
Nashine S. Potential therapeutic candidates for age-related macular degeneration (AMD)[J]. Cells, 2021, 10(9): 2483. DOI: 10.3390/cells10092483.
|